SL-012

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSL-012
Drug Alias NameSL-012
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSea Lane Biotechnologies LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSea Lane Biotechnologies LLC
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A